Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review
Eva Montanari, Graziella Madeo, Simona Pichini, et al.
Therapeutic Drug Monitoring (2022) Vol. 44, Iss. 4, pp. 494-510
Closed Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

High-throughput quantification of emerging “nitazene” benzimidazole opioid analogs by microextraction and UHPLC–MS-MS
Maria Schüller, Ivana Lučić, Åse Marit Leere Øiestad, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 9, pp. 787-796
Open Access | Times Cited: 16
Shifting drug markets in North America - a global crisis in the making?
Maximilian Meyer, Jean N. Westenberg, Kerry L. Jang, et al.
International Journal of Mental Health Systems (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 15
Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes
Gajanan Raosaheb Jadhav, Pius S. Fasinu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats
Sara E. Walton, Alex J. Krotulski, Grant C. Glatfelter, et al.
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 185-198
Closed Access | Times Cited: 19
Rapid screening of 2‐benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART‐TD‐MS, and FT‐IR
Martin M. Kimani, Sara E. Kern, Adam Lanzarotta, et al.
Drug Testing and Analysis (2023) Vol. 15, Iss. 5, pp. 539-550
Closed Access | Times Cited: 12
Evaluation of fentanyl immunoassay test strips for rapid in-situ detection of fentanyl and fentanyl analogs in seized samples and alternative matrices
Caitlyn Norman, Victoria Marland, Craig McKenzie, et al.
International Journal of Drug Policy (2023) Vol. 118, pp. 104102-104102
Open Access | Times Cited: 11
Testing for protonitazene in human hair using LC–MS-MS
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 8, pp. 630-635
Closed Access | Times Cited: 4
Navigating nitazenes: A pharmacological and toxicological overview of new synthetic opioids with a 2-benzylbenzimidazole core
Marthe M. Vandeputte, Christophe P. Stove
Neuropharmacology (2025), pp. 110470-110470
Closed Access
Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling
Diletta Berardinelli, Johannes Kutzler, Omayema Taoussi, et al.
Archives of Toxicology (2025)
Open Access
High‐Resolution LC‐MS Approach for In Vitro Metabolite Characterisation of Etonitazene in Camels for Enhanced Doping Control
Jahfar Nalakath, Ibrahim Waseem Nelliyott, Ahmed Kadry, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 15
Closed Access
Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
Annagiulia Di Trana, Diletta Berardinelli, Eva Montanari, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14619-14619
Open Access | Times Cited: 17
Postmortem examination and toxicological analysis for acute metonitazene intoxication in Japan: A case report
Fumiya Morioka, Shihoko Fujii, Hiroe Kamata, et al.
Legal Medicine (2023) Vol. 61, pp. 102216-102216
Open Access | Times Cited: 10
Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States
Kristin E. Schneider, Emily Martin, Sean T. Allen, et al.
International Journal of Drug Policy (2024) Vol. 126, pp. 104371-104371
Closed Access | Times Cited: 3
First evidence in an oversea French department of the deadly risk of protonitazene use: about 5 post mortem cases
Christophe Maruéjouls, Alice Ameline, Laurie Gheddar, et al.
International Journal of Legal Medicine (2024)
Closed Access | Times Cited: 3
Detection of N-desethyl etonitazene in a drug checking sample: chemical analysis and pharmacological characterization of a recent member of the 2-benzylbenzimidazole “nitazene” class
Manuela Carla Monti, Liam M. De Vrieze, Marthe M. Vandeputte, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 251, pp. 116453-116453
Open Access | Times Cited: 3
The use of wastewater based epidemiology to detect synthetic opioids in the community
Richard Bade, Wayne Hall
BMJ (2024), pp. q5-q5
Closed Access | Times Cited: 2
Metabolism and detection of designer benzodiazepines; A systematic review
PS Gameli, M HUESTIS, Aurora Balloni, et al.
Drug Metabolism Reviews (2024), pp. 1-32
Closed Access | Times Cited: 2
Metabolism of Six Novel Nitazenes in Human Liver Microsomes Based on Ultra‐High‐Performance Liquid Chromatography Coupled With High‐Resolution Mass Spectrometry
Boxian Huang, Zhendong Hua, Cuimei Liu, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 2
Acute metonitazene poisoning reversed by naloxone
Adam White, Vincent Seah, Jared A Brown, et al.
Clinical Toxicology (2023) Vol. 61, Iss. 2, pp. 137-138
Closed Access | Times Cited: 6
β′-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Annagiulia Di Trana, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 9, pp. e207-e217
Closed Access | Times Cited: 9
Drug checking services as a surveillance tool for clinical laboratories: Examining trends in the unregulated fentanyl supply
Sarah Delaney, Danijela Konforte, Cristiana Stefan, et al.
Clinical Biochemistry (2022) Vol. 111, pp. 11-16
Closed Access | Times Cited: 8
Nitazene opioids and the heart: Identification of a cardiac ion channel target for illicit nitazene opioids
Jules C. Hancox, Yibo Wang, Caroline S. Copeland, et al.
Journal of Molecular and Cellular Cardiology Plus (2024) Vol. 10, pp. 100118-100118
Open Access | Times Cited: 1
Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice
Marthe M. Vandeputte, Grant C. Glatfelter, Donna Walther, et al.
Pharmacological Research (2024) Vol. 210, pp. 107503-107503
Open Access | Times Cited: 1
Non-fatal overdose with a new synthetic opioid
Marcus Stangeland, Torbjørn Lunde, Kjell Ove Fossan, et al.
Tidsskrift for Den norske legeforening (2024)
Open Access | Times Cited: 1
New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Simona Napoletano, Giuseppe Basile, Alfredo Fabrizio Lo Faro, et al.
PubMed (2022) Vol. 93, Iss. 2, pp. e2022186-e2022186
Closed Access | Times Cited: 5

Scroll to top